CompletedPhase 2NCT00064298
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
Studying Squamous cell carcinoma of head and neck
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Wake Forest University Health Sciences
- Principal Investigator
- Steven A. Akman, MDWake Forest University Health Sciences
- Intervention
- fruit and vegetable extracts(dietary_supplement)
- Enrollment
- 134 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2009
Study locations (28)
- CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States
- Redwood Regional Medical Group, Santa Rosa, California, United States
- CCOP - Christiana Care Health Services, Newark, Delaware, United States
- MBCCOP - Howard University Cancer Center, Washington D.C., District of Columbia, United States
- University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States
- CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States
- MBCCOP - JHS Hospital of Cook County, Chicago, Illinois, United States
- CCOP - Central Illinois, Decatur, Illinois, United States
- CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
- Cedar Rapids Oncology Associates, Cedar Rapids, Iowa, United States
- MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States
- Feist-Weiller Cancer Center at Louisiana State University Health Sciences, Shreveport, Louisiana, United States
- CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States
- CCOP - Beaumont, Royal Oak, Michigan, United States
- CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
- +13 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00064298 on ClinicalTrials.govOther trials for Squamous cell carcinoma of head and neck
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07333274Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell CarcinomaShandong Cancer Hospital and Institute
- RECRUITINGPHASE3NCT07026474Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCCUniversität des Saarlandes
- RECRUITINGPHASE1NCT07182149A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsNormunity AccelCo, Inc.
- RECRUITINGNANCT07203911Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled TrialTobias Todsen
- RECRUITINGNANCT07180901Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck CancerCentre hospitalier de l'Université de Montréal (CHUM)
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07435415Local Injection Methylene Blue Combined With Radiation in HNSCC PatientsChina Medical University Hospital
- RECRUITINGPHASE2NCT07088211Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCCShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- RECRUITINGPHASE2NCT07040956A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.West China Hospital
See all trials for Squamous cell carcinoma of head and neck →